Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality
Wei M., Gibbons L.W., Mitchell T.L., et al. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 101 (2000) 2047-2052
Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow up
Fisman E.Z., Motro M., Tenenbaum A., et al. Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow up. Eur J Cardiovasc Prevent Rehab 11 (2004) 135-143
Central pontine myelinolysis and myocardial infarction following severe hypoglycemia
Purucker E., Nguyen H.N., Lammert F., Koch A., and Matern S. Central pontine myelinolysis and myocardial infarction following severe hypoglycemia. Intensive Care Med 26 (2000) 1406-1407
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
UK Prospective Diabetes Study (UKPDS) Group
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
Altered ventricular repolarization during hypoglycaemia in patients with diabetes
Marques J.L., George E., Peacey S.R., et al. Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabet Med 14 (1997) 648-654
Vasoconstriction of stenotic coronary arteries during dynamic exercise in patient with classic angina pectoris: reversibility with nitroglycerin
Gage J.E., Hess O.M., Murakami T., et al. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patient with classic angina pectoris: reversibility with nitroglycerin. Circulation 73 (1986) 865-876